Perspectives in Polycystic Ovary Syndrome: From Hair to Eternity

The Journal of Clinical Endocrinology and Metabolism
Andrea Dunaif

Abstract

Polycystic ovary syndrome (PCOS) is a common complex genetic disease. It is characterized by hyperandrogenism, gonadotropin secretory changes, polycystic ovarian morphology, and insulin resistance. The etiology of PCOS remains unknown, but modern genetic approaches, such as genome-wide association studies (GWAS), Mendelian randomization, and next-generation sequencing, promise to identify the pathways that are primarily disrupted. The literature on PCOS, including the author's research, is discussed. Recent genetic analyses are reviewed. Considerable progress has been made mapping PCOS susceptibility genes. GWAS have implicated gonadotropin secretion and action as important primary defects in disease pathogenesis in European and Han Chinese PCOS cohorts, respectively. European women with the National Institutes of Health and Rotterdam phenotypes as well as those with self-reported PCOS have some gene regions in common, such as chromosome 11p14.1 region containing the FSH B polypeptide (FSHB) gene, suggesting shared genetic susceptibility. Several chromosomal signals are significant in both Han Chinese and European PCOS cohorts, suggesting that the susceptibility genes in these regions are evolutionarily conserved. In addition, ...Continue Reading

Citations

Mar 10, 2017·International Journal of Impotence Research·S V KellesarianF Javed
Jan 10, 2018·Journal of Developmental Origins of Health and Disease·E S BarrettS H Swan
Feb 16, 2019·Expert Review of Endocrinology & Metabolism·David H AbbottJon E Levine
Jun 27, 2018·Journal of Molecular Endocrinology·Muraly Puttabyatappa, Vasantha Padmanabhan
Feb 28, 2018·Scientific Reports·Soha R DarghamStephen L Atkin
Oct 14, 2017·Endocrine Reviews·JoAnne S RichardsAleksandar Rajkovic
Apr 6, 2019·Endocrinology·Nicholes R CandelariaJoAnne S Richards
May 1, 2019·The Journal of Clinical Endocrinology and Metabolism·Matthew DapasM Geoffrey Hayes
Apr 6, 2017·Proceedings of the National Academy of Sciences of the United States of America·David H Abbott
Apr 2, 2020·The Journal of Clinical Endocrinology and Metabolism·Anna BenrickElisabet Stener-Victorin
Apr 21, 2020·Endocrine Reviews·Elisabet Stener-VictorinDavid H Abbott
Aug 28, 2018·Frontiers in Endocrinology·Stephen Franks, Kate Hardy
Jun 21, 2019·Hormone Molecular Biology and Clinical Investigation·Elgina SvetlanaBeglova Anzhelika
Jul 13, 2019·Current Opinion in Pediatrics·Selma F WitchelSharon E Oberfield
Mar 24, 2017·Human Reproduction·D H AbbottJ E Levine
Nov 7, 2019·International Journal of Molecular Sciences·Michele d'AngeloElisabetta Benedetti
Feb 25, 2017·Current Opinion in Endocrinology, Diabetes, and Obesity·Adina F Turcu, Richard J Auchus
Aug 7, 2020·Archives of Gynecology and Obstetrics·Chunren ZhangHongxia Ma
Feb 2, 2021·Endocrinology and Metabolism Clinics of North America·John S Rushing, Nanette Santoro
Feb 2, 2021·Endocrinology and Metabolism Clinics of North America·Sydney Chang, Andrea Dunaif
Sep 14, 2019·Endocrine Regulations·Laura M L CarvalhoKarina B Gomes
Apr 21, 2021·Reproductive Biology·Aynaz MihanfarMohammad Hassan Khadem-Ansari
Oct 4, 2019·Current Medicinal Chemistry·Alicia Beatriz Motta

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.